TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,806,000 | -42.1% | 365,205 | +2.8% | 0.00% | -40.0% |
Q4 2021 | $16,943,000 | -9.5% | 355,193 | +26.1% | 0.01% | 0.0% |
Q3 2021 | $18,715,000 | -16.0% | 281,724 | -1.3% | 0.01% | -16.7% |
Q2 2021 | $22,267,000 | +27.5% | 285,401 | +54.6% | 0.01% | +20.0% |
Q1 2021 | $17,467,000 | -24.1% | 184,659 | -2.3% | 0.01% | -28.6% |
Q4 2020 | $23,023,000 | +116.6% | 188,948 | +55.3% | 0.01% | +75.0% |
Q3 2020 | $10,628,000 | – | 121,663 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |